Elevated levels of circulating plasma matrix metalloproteinase 9 in non- small cell lung cancer patients

Clinical Cancer Research

Volumn 5, Issue 1, 1999, Pages 149-153

  Iizasa, Toshihiko ^a   Fujisawa, Takehiko ^a   Suzuki, Makoto ^a   Motohashi, Shin Ichirou ^a   Yasufuku, Kazuhiro ^a   Yasukawa, Tomohisa ^a   Baba, Masayuki ^a   Shiba, Mitsutoshi ^a  

^a CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GELATINASE A; GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL FEATURE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; COLLAGENASES; FEMALE; GELATINASES; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; METALLOENDOPEPTIDASES; MIDDLE AGED; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 0032926187     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Matristian, L. M. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet., 6: 121-125, 1990.
2. Huhtala, P., Tuuttila, A., Chow, L. T., Lohi, J., Keski-Oja, J., and Tryggvason, K. Complete structure of the human gene for 92-kDa type IV collagenase. J. Biol. Chem., 266: 16485-16490, 1991.
3. Stetler-Stevenson, W. G. Dynamics of matrix turnover during pathologic remodeling of the extracellular matrix. Am. J. Pathol., 148: 1345-1350, 1996.
4. Liotta, L. A., Abe, S., Robey, P. G., and Martin, G. R. Preferential digestion of basement membrane collagen by an enzyme derived from a metastatic murine tumor. Proc. Natl. Acad. Sci. USA, 76:2268-2272, 1979.
5. Liotta, L. A., Tryggvason, K., Garbisa, S., Hart, I., Foltz, C. M., and Shafie, S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature (Lond.), 284: 67-68, 1980.
6. Tryggvason, K., Höyhtyä, M., and Pyke, C. Type IV collagenases in invasive tumors. Breast Cancer Res. Treat., 24: 209-218, 1993.
7. Wilhelm, S. M., Collier, I. E., Manner, B. L., Eisen, A. Z., Grant, G. A., and Goldberg, G. I. SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J. Biol. Chem., 264: 17213-17221, 1989.
8. Nielsen, B. S., Timshel, S., Kjeldsen, L., Maxwell, S., Pyke, C., Borregaard, N., and Danø, K. 92 kDa type IV collagenase (MMP-9) is expressed in neutrophils and macrophages but not in malignant epithelial cells in human colon cancer. Int. J. Cancer, 65: 57-62, 1996.
9. Pyke, C., Ralfkiær, E., Tryggvason, K., and Danø, K. Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer. Am. J. Pathol., 142: 359-365, 1993.
10. Himelstein, B. P., and Muschel, R. J. Induction of metalloproteinase 9 expression in breast carcinoma cells by a soluble factor from fibroblasts. Clin. Exp. Metastasis, 14: 197-208, 1993.
11. Monteagudo, C., Merino, M. J., San-Juan, J., Liotta, L. A., and Stetler-Stevenson, W. G. Immunohistochemical distribution of type IV collagenase in normal, benign, and malignant breast tissue. Am. J. Pathol., 136: 585-592, 1990.
12. Iwata, H., Kobayashi, S., Iwase, H., Masaoka, A., Fujimoto, N., and Okada, Y. Production of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human breast carcinomas. Jpn. J. Cancer Res., 87: 602-611, 1996.
13. Brown, P. D., Bloxidge, R. E., Anderson, E., and Howell, A. Expression of activated gelatinase in human invasive breast carcinoma. Clin. Exp. Metastasis, 11: 183-189, 1993.
14. Jeziorska, M., Haboubi, N. Y., Schofield, P. F., Ogata, Y., Nagase, H., and Woolley, D. E. Distribution of gelatinase B (MMP-9) and type IV collagen in colorectal carcinoma. Int. J. Colorectal Dis., 9: 141-148, 1994.
15. r 92,000 type IV collagenase in human brain tumors. Cancer Res., 53: 2208-2211, 1993.
16. Nakagawa, T., Kubota, T., Kabuto, M., Sato, K., Kawano, M., Hayakawa, T., and Okada, Y. Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors. J. Neurosurg., 81: 69-77, 1994.
17. Sato, H., Kida, Y., Mai, M., Endo, Y., Sasaki, T., Tanaka, J., and Seiki, M. Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells. Oncogene, 7: 77-83, 1992.
18. Urbanski, S. J., Edwards, D. R., Maitland, A., Leco, K. J., Watson, A., and Kossakowska, A. E. Expression of metalloproteinases and their inhibitors in primary pulmonary carcinomas. Br. J. Cancer, 66: 1188-1194, 1992.
19. Brown, P. D., Bloxidge, R. E., Stuart, N. S. A., Gatter, K. C., and Carmichael, J. Expression of activated 72-kilodalton gelatinase and tumor spread in non-small-cell lung carcinoma. J. Natl. Cancer Inst., 85: 573-578, 1993.
20. Fujimoto, N., Hosokawa, N., Iwata, K., Shinya, T., Okada, Y., and Hayasaka, T. A one-step sandwich enzyme immunoassay for inactive precursor and complexed forms of human matrix metalloproteinase 9 (92 kDa gelatinase/type IV collagenase, gelatinase B) using monoclonal antibodies. Clin. Chim. Acta, 231: 79-88, 1994.
21. Mountain, C. F. Revision in the international system for staging lung cancer. Chest, 111: 1710-1717, 1997.
22. American Joint Committee on Cancer. Manual for Staging of Cancer. 4th ed., pp. 115-122. Philadelphia: J. B. Lippincott, 1992.
23. The Japan Lung Cancer Society. The General Rule for Clinical and Pathological Record of Lung Cancer, pp. 89-121. Tokyo: Kanehara Press, 1995.
24. Kawahara, E., Okada, Y., Nakanishi, I., Iwata, K., Kojima, S., Kumagai, S., and Yamamoto, E. The expression of invasive behavior of a differentiated squamous carcinoma cell line evaluated by an in vitro invasion model. Jpn. J. Cancer Res., 84: 409-418, 1993.
25. Liotta, L. A., Steeg, P. S., and Stetler-Stevenson, W. G. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell, 64: 327-336, 1991.
26. r 92,000 gelatinase secreted by normal and malignant human cells: isolation and characterization of the enzyme from HT1080 tumor cells. Cancer Res., 50: 6162-6170, 1990.
27. r 92,000 gelatinase release correlates with the metastatic phenotype in transformed rat embryo cells. Cancer Res., 50: 3872-3877, 1990.
28. Nakajima, M., Welch, D. R., Belloni, P. N., and Nicolson, G. L. Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat adenocarcinoma cell clones of differing metastatic potentials. Cancer Res., 47: 4869-4876, 1987.
29. Iizasa, T., Momiki, S., Bauer, B., Caamano, J., Metcalf, R., Lechner, J., Harris, C. C., and Klein-Szanto, A. J. Invasive tumors derived from xenotransplanted, immortalized human cells after in vivo exposure to chemical carcinogens. Carcinogenesis (Lend.), 14: 1789-1794, 1993.
30. Stetler-Stevenson, W. G. Type IV collagenase in tumor invasion and metastasis. Cancer Metastasis Rev., 9: 289-303, 1990.
31. Torii, A., Kodera, Y., Uesaka, K., Hirai, T., Yasui, K., Morimoto, T., Yamamura, Y., Kato, T., Hayakawa, T., Fujimoto, N., and Kito, T. Plasma concentration of matrix metalloproteinases 9 in gastric cancer. Br. J. Surg., 84: 133-136, 1997.
32. Hayasaka, A., Suzuki, N., Fujimoto, N., Iwama, S., Fukuyama, E., Kanda, Y., and Saisho, H. Elevated plasma levels of matrix metalloproteinase-9 (92-kd type IV collagenase/gelatinase B) in hepatocellular carcinoma. Hepatology, 24: 1058-1062, 1996.
33. Zucker, S., Lysik, R. M., Gurfinkel, M., Zarrabi, M. H., Stetler-Stevenson, W., Liotta, L. A., Birkedal-Hansen, H., and Mann, W. Immunoassay of type IV collagenase/gelatinase (MMP-2) in human plasma. J. Immunol. Methods, 148: 189-198, 1992.
34. r 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer. Cancer Res., 55: 140-146, 1993.
35. 1 adenocarcinoma of the lung. Pathol. Int., 47: 461-469, 1997.
36. Nomura, H., Fujimoto, M., Seiki, M., Mai, M., and Okada, Y. Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas. Int. J. Cancer, 69: 9-16, 1996.
37. Woessner, J. F. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J., 5: 2145-2154, 1991.
38. O'Connor, C. M., and FitzGerald, M. X. Matrix metalloproteases and lung disease. Thorax, 49: 602-609, 1994.